Cargando…
Malaria-associated adhesion molecule activation facilitates the destruction of uninfected red blood cells
Severe malarial anemia (SMA) is the main cause of malaria-associated infant mortality in malaria endemic countries. One major factor that contributes to SMA is the accumulation of uninfected red blood cells (uRBCs) in the spleen. We report the activation of adhesion molecules Lutheran/basal cell adh...
Autores principales: | Dalimot, Jill J., Klei, Thomas R.L., Beuger, Boukje M., Dikmen, Zeynep, Bouwman, Suzan A.M., Mombo-Ngoma, Ghyslain, Zoleko-Manego, Rella, Ndzebe-Ndoumba, Wilfrid F., Egée, Stéphane, Kuijpers, Taco W., Grobusch, Martin P., van Bruggen, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647827/ https://www.ncbi.nlm.nih.gov/pubmed/35349634 http://dx.doi.org/10.1182/bloodadvances.2021006171 |
Ejemplares similares
-
Performance of Field’s Stain Compared with Conventional Giemsa Stain for the Rapid Detection of Blood Microfilariae in Gabon
por: Ekoka Mbassi, Franck-A., et al.
Publicado: (2022) -
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study
por: Zoleko-Manego, Rella, et al.
Publicado: (2022) -
Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial
por: Zoleko-Manego, Rella, et al.
Publicado: (2023) -
A comparison of different scores for diagnosis and mortality prediction of adults with sepsis in Low-and-Middle-Income Countries: a systematic review and meta-analysis
por: Adegbite, Bayode R, et al.
Publicado: (2021) -
Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults – a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial
por: Ekoka Mbassi, Dorothea, et al.
Publicado: (2023)